Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3515)
Akebia Therapeutics, Inc. (AKBA)
Malabre Richard C — SVP, Chief Accounting Officer
Shares
36,142
Price
$1.39
Total Value
$50.24K
Shares Held After
312,772
% of Holdings
10.4%
ALX ONCOLOGY HOLDINGS INC (ALXO)
GOODMAN COREY S — Director
Shares
3,184,713
Price
$1.57
Total Value
$5.00M
Shares Held After
8,453,038
% of Holdings
37.7%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
968
Price
$103.30
Total Value
$100.00K
Shares Held After
4,503
% of Holdings
17.7%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
9,108
Price
$103.30
Total Value
$940.89K
Shares Held After
160,294
% of Holdings
5.4%
Mirum Pharmaceuticals, Inc. (MIRM)
Radovich Peter — PRESIDENT AND COO
Shares
2,631
Price
$103.30
Total Value
$271.79K
Shares Held After
20,655
% of Holdings
11.3%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
365
Price
$21.38
Total Value
$7.80K
Shares Held After
639,505
% of Holdings
0.1%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
366
Price
$21.38
Total Value
$7.83K
Shares Held After
639,507
% of Holdings
0.1%
Centessa Pharmaceuticals plc (CNTA)
HUSSAIN IQBAL J — Chief Legal Officer
Shares
38,951
Price
$25.15
Total Value
$979.66K
Shares Held After
57,645
% of Holdings
40.3%
BioAge Labs, Inc. (BIOA)
RUBIN PAUL D — Chief Medical Officer
Shares
7,433
Price
$18.75
Total Value
$139.37K
Shares Held After
0
% of Holdings
100.0%
Zenas BioPharma, Inc. (ZBIO)
MOULDER LEON O JR — Director
Shares
57,000
Price
$17.96
Total Value
$1.02M
Shares Held After
423,155
% of Holdings
13.5%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
7,875
Price
$470.95
Total Value
$3.71M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14,625
Price
$470.95
Total Value
$6.89M
Shares Held After
0
% of Holdings
100.0%
Serina Therapeutics, Inc. (SER)
Moreadith Randall — Chief Scientific Officer
Shares
6,500
Price
$3.03
Total Value
$19.68K
Shares Held After
0
% of Holdings
100.0%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
22,000
Price
$7.71
Total Value
$169.67K
Shares Held After
1,144,391
% of Holdings
1.9%
Ultragenyx Pharmaceutical Inc. (RARE)
Horn Howard — Chief Financial Officer
Shares
3,061
Price
$23.56
Total Value
$72.12K
Shares Held After
88,935
% of Holdings
3.3%
Alkermes plc. (ALKS)
Cooke Shane — Director
Shares
32,113
Price
$34.78
Total Value
$1.12M
Shares Held After
103,744
% of Holdings
23.6%
Alkermes plc. (ALKS)
Cooke Shane — Director
Shares
29,087
Price
$34.34
Total Value
$998.80K
Shares Held After
135,857
% of Holdings
17.6%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
4,000
Price
$33.54
Total Value
$134.16K
Shares Held After
57,740
% of Holdings
6.5%
Alkermes plc. (ALKS)
Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Shares
5,000
Price
$34.24
Total Value
$171.22K
Shares Held After
61,740
% of Holdings
7.5%
Solid Biosciences Inc. (SLDB)
Herzich Paul — Chief Technology Officer
Shares
26,250
Price
$6.44
Total Value
$168.97K
Shares Held After
79,972
% of Holdings
24.7%
Solid Biosciences Inc. (SLDB)
Howton David T — Chief Operating Officer
Shares
37,771
Price
$6.44
Total Value
$243.13K
Shares Held After
116,753
% of Holdings
24.4%
Solid Biosciences Inc. (SLDB)
Hanrahan Jessie — Chief Regulatory Officer
Shares
26,535
Price
$6.44
Total Value
$170.80K
Shares Held After
82,675
% of Holdings
24.3%
Solid Biosciences Inc. (SLDB)
Brooks Gabriel — Chief Medical Officer
Shares
28,335
Price
$6.44
Total Value
$182.39K
Shares Held After
96,708
% of Holdings
22.7%
Solid Biosciences Inc. (SLDB)
Cumbo Alexander — Director
Shares
80,258
Price
$6.44
Total Value
$516.61K
Shares Held After
270,931
% of Holdings
22.9%
Solid Biosciences Inc. (SLDB)
Tan Kevin — CFO & Treasurer
Shares
26,837
Price
$6.44
Total Value
$172.75K
Shares Held After
108,984
% of Holdings
19.8%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
32,410
Price
$185.60
Total Value
$6.02M
Shares Held After
7,229
% of Holdings
81.8%
ABEONA THERAPEUTICS INC. (ABEO)
Crombez Eric — Director
Shares
16,284
Price
$5.09
Total Value
$82.90K
Shares Held After
63,456
% of Holdings
20.4%
ABEONA THERAPEUTICS INC. (ABEO)
Wuchterl Donald A. — Director
Shares
14,814
Price
$5.09
Total Value
$75.41K
Shares Held After
167,935
% of Holdings
8.1%
Xeris Biopharma Holdings, Inc. (XERS)
Hecht Beth — Chief Legal Officer and Corporate Secretary
Shares
16,667
Price
$7.45
Total Value
$124.15K
Shares Held After
1,243,174
% of Holdings
1.3%
FENNEC PHARMACEUTICALS INC. (FENC)
Raykov Rosty — Director
Shares
10,349
Price
$7.76
Total Value
$80.31K
Shares Held After
98,477
% of Holdings
9.5%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
3,800
Price
$4.04
Total Value
$15.35K
Shares Held After
555,559
% of Holdings
0.7%
ZEVRA THERAPEUTICS, INC. (ZVRA)
McFarlane Neil F. — Director
Shares
91,000
Price
$9.38
Total Value
$853.43K
Shares Held After
364,350
% of Holdings
20.0%
ABEONA THERAPEUTICS INC. (ABEO)
Alland Leila — Director
Shares
18,065
Price
$5.09
Total Value
$91.96K
Shares Held After
173,614
% of Holdings
9.4%
ABEONA THERAPEUTICS INC. (ABEO)
Alvino Mark — Director
Shares
2,000
Price
$5.09
Total Value
$10.18K
Shares Held After
84,065
% of Holdings
2.3%
CYTOKINETICS INC (CYTK)
Callos Andrew — EVP, Chief Commercial Officer
Shares
886
Price
$62.10
Total Value
$55.02K
Shares Held After
50,440
% of Holdings
1.7%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,135
Price
$21.39
Total Value
$45.67K
Shares Held After
639,140
% of Holdings
0.3%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
2,136
Price
$21.39
Total Value
$45.69K
Shares Held After
639,141
% of Holdings
0.3%
Centessa Pharmaceuticals plc (CNTA)
HUSSAIN IQBAL J — Chief Legal Officer
Shares
1,010
Price
$25.01
Total Value
$25.26K
Shares Held After
104,376
% of Holdings
1.0%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
5,296
Price
$82.96
Total Value
$439.36K
Shares Held After
45,413
% of Holdings
10.4%
IONIS PHARMACEUTICALS INC (IONS)
Birchler Brian — EVP, Corp and Development Ops
Shares
6,179
Price
$83.03
Total Value
$513.05K
Shares Held After
66,247
% of Holdings
8.5%
IONIS PHARMACEUTICALS INC (IONS)
O'NEIL PATRICK R. — EVP CLO & General Counsel
Shares
6,179
Price
$83.53
Total Value
$516.15K
Shares Held After
71,983
% of Holdings
7.9%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
6,988
Price
$83.24
Total Value
$581.70K
Shares Held After
132,881
% of Holdings
5.0%
IONIS PHARMACEUTICALS INC (IONS)
BENNETT C FRANK — EVP, Chief Scientific Officer
Shares
5,885
Price
$82.95
Total Value
$488.14K
Shares Held After
100,293
% of Holdings
5.5%
IONIS PHARMACEUTICALS INC (IONS)
Schneider Eugene — EVP, Chf Clinical Develop Ofcr
Shares
6,179
Price
$83.45
Total Value
$515.63K
Shares Held After
69,702
% of Holdings
8.1%
IONIS PHARMACEUTICALS INC (IONS)
Swayze Eric — EVP Research
Shares
6,179
Price
$82.93
Total Value
$512.45K
Shares Held After
47,747
% of Holdings
11.5%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
62,970
Price
$82.72
Total Value
$5.21M
Shares Held After
283,927
% of Holdings
18.2%
Royalty Pharma plc (RPRX)
Urist Marshall — EVP, Research & Investments
Shares
20,000
Price
$41.09
Total Value
$821.81K
Shares Held After
0
% of Holdings
100.0%
Clene Inc. (CLNN)
Ugwumba Chidozie — 10% Owner
Shares
5,686
Price
$4.13
Total Value
$23.48K
Shares Held After
559,359
% of Holdings
1.0%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Quartel Adrian W — Chief Medical Officer
Shares
4,533
Price
$8.83
Total Value
$40.04K
Shares Held After
9,723
% of Holdings
31.8%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Schafer Joshua — CCO
Shares
3,375
Price
$8.83
Total Value
$29.80K
Shares Held After
37,444
% of Holdings
8.3%
Showing 2001–2050 of 3515 transactions (page 41 of 71)